Akèy › Maladi dejeneratif nè
Etid klinik pou Maladi dejeneratif nè ap rekrite nan Etazini
32 etid pou Maladi dejeneratif nè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Philadelphia, PA6 etid
- Tampa, FL5 etid
- Orlando, FL5 etid
- Boston, MA5 etid
- Atlanta, GA4 etid
- Scottsdale, AZ4 etid
- San Diego, CA4 etid
- Dallas, TX3 etid
- New York City, NY3 etid
- Baltimore, MD3 etid
- West Palm Beach, FL3 etid
- Miami, FL3 etid
- Farmington Hills, MI3 etid
- San Francisco, CA3 etid
- Austin, TX3 etid
- Boca Raton, FL3 etid
- Denver, CO3 etid
- Gainesville, FL3 etid
- Los Angeles, CA3 etid
- Chicago, IL3 etid
Pa eta
- Arizona4 etid
- Colorado5 etid
- Connecticut4 etid
- Florid8 etid
- Georgia5 etid
- Illinois4 etid
- Kalifòni10 etid
- Kansas3 etid
- Maryland4 etid
- Massachusetts6 etid
- Michigan4 etid
- New York4 etid
- North Carolina3 etid
- Ohio4 etid
- Oregon3 etid
- Pennsylvania6 etid
- Tennessee3 etid
- Texas8 etid
- Washington4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Weeks · Tout sèks · Mizajou Sep 29, 2026 · NCT00271622An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
Ap rekriteFaz 1/2
6 Months · Tout sèks · Mizajou Sep 24, 2026 · NCT05757141A Study of LY3439539 in Participants With Alzheimer's Disease
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595Home Exercise for Individuals With Neurodegenerative Disease
Ap rekriteVolontè an sante akeyi
Laj 5 a 75 · Tout sèks · Mizajou Sep 16, 2026 · NCT05443906Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Fanm · Mizajou Sep 14, 2026 · NCT07758114A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615Observational Pharmaco-Epidemiology Research & Analysis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT03813862Human Observatory Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07646782Parkinson Progression Marker Initiative Online (PPMI Online)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05065060Biofluid Research on Age-Related or Inherited Neurodegeneration
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07798700Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Sep 1, 2026 · NCT06016946Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06993142A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Ap rekriteFaz 1
Laj 40 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06482268Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
Ap rekriteFaz 4Volontè an sante akeyi
Laj 50 a 85 · Tout sèks · Mizajou Aug 7, 2026 · NCT05357612PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Imaging Studies in Corticobasal Syndrome
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07000851Analysis of Human ALS Tissues and Registry of ALS Patients
Ap rekriteEtid obsèvasyon
Laj 18 a 90 · Tout sèks · Mizajou Jul 8, 2026 · NCT05067179Neurologic Stem Cell Treatment Study
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT02795052Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Ap rekriteVolontè an sante akeyi
Laj 40 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT05741853F 18 T807 Tau PET Imaging of Alzheimer's Disease
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT02414347Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)
Ap rekriteFaz 1
Laj 10 a 25 · Tout sèks · Mizajou Apr 22, 2026 · NCT07543991Intervention for Communication Quality of Life in Primary Progressive Aphasia
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT07219680Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.